Lampang Hospital is the main hospital of Lampang Province, Thailand, classified under the Ministry of Public Health as a regional hospital. It serves as the tertiary-care transfer hospital for patients in Phrae and Nan Provinces. Established in 1930, the hospital has a CPIRD Medical Education Center, training doctors for the Faculty of Medicine of Chiang Mai University.

As a regional hospital, Lampang Hospital offers a wide range of medical specialties and services, including general medicine, surgery, pediatrics, obstetrics and gynecology, and more. Specific specialty departments are not detailed in the available information.​

Lampang Hospital is committed to providing high-quality healthcare services to the community. It also functions as a teaching hospital, contributing to the education and training of future medical professionals.​

Vision

To become a high-performance cancer hospital specializing in technology and medical innovation, with the ultimate goal of improving people's quality of life.

Mission

• Quality Cancer Care: Provide comprehensive cancer diagnosis, treatment, and care services to ensure a good quality of life for patients.

• Academic Development: Focus on knowledge transfer and academic advancement in cancer care.

• Network Collaboration: Deliver cancer care services through partnerships with network hospitals and health regions.

• Strategic Adaptation: Continuously adjust strategies to address changes in social conditions, technology, and emerging diseases.

• 25th Anniversary Recognition: In 2024, Lampang Cancer Hospital celebrated its 25th anniversary, marking its significant role as one of the seven regional cancer hospitals in Thailand. This recognition highlights its contributions to cancer services and the establishment of population-based cancer registries, which meet World Health Organization standards.

• Membership in International Association for Cancer Registries (IACR): The Lampang Cancer Registry has been a voting member of the IACR since May 2002, showcasing its commitment to maintaining high-quality cancer data and contributing to international research on cancer incidence and trends.